Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24
United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Bart Jan Cornelissen
10 Apr 2026
Sr. Vice President & CFO
Sell
3,499
$12.29
$42.99K
Bassil I Dahiyat
6 Mar 2026
President & CEO
Sell
6,606
$11.02
$72.80K
Celia Eckert
6 Mar 2026
SVP, General Counsel
Sell
1,767
$11.02
$19.47K
John R Desjarlais
6 Mar 2026
Sr. Vice President & CSO
Sell
2,502
$11.02
$27.57K
Bassil I Dahiyat
5 Mar 2026
President & CEO
Sell
14,870
$11.25
$167.22K
Bart Jan Cornelissen
5 Mar 2026
Sr. Vice President & CFO
Sell
2,517
$11.25
$28.30K
Celia Eckert
5 Mar 2026
SVP, General Counsel
Sell
3,244
$11.25
$36.48K
John R Desjarlais
5 Mar 2026
Sr. Vice President & CSO
Sell
4,118
$11.25
$46.31K
Bassil I Dahiyat
3 Mar 2026
President & CEO
Sell
6,758
$11.90
$80.39K
Celia Eckert
3 Mar 2026
SVP, General Counsel
Sell
1,492
$11.90
$17.75K
John R Desjarlais
3 Mar 2026
Sr. Vice President & CSO
Sell
2,663
$11.90
$31.68K

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 2
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 452,753
History held since 6 Dec 2013